First Citizens Bank & Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-19,681
Closed -$1.5M 408
2019
Q3
$1.5M Sell
19,681
-577
-3% -$48K 0.18% 136
2019
Q2
$1.78M Buy
+20,258
New +$1.73M 0.19% 126

Other funds holding XBI

First Citizens Bank & Trust's XBI Position: Q4 2019 in Review

First Citizens Bank & Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2019, closing a stake of 19,681 shares — an estimated $1.5M sold.

First Citizens Bank & Trust first reported a position in XBI in Q2 2019 and held it in 2 quarters. The position peaked at $1.78M in Q2 2019. 474 funds tracked by Wall St. Rank hold XBI as of Q4 2019.

  • First Citizens Bank & Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2019 after selling out during the quarter.
  • First Citizens Bank & Trust sold 19,681 State Street SPDR S&P Biotech ETF shares in Q4 2019, an estimated $1.5M.
  • First Citizens Bank & Trust first reported a position in State Street SPDR S&P Biotech ETF in Q2 2019 and held it in 2 quarters.
  • First Citizens Bank & Trust's State Street SPDR S&P Biotech ETF position peaked at $1.78M in Q2 2019.
  • 474 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2019.

Based on First Citizens Bank & Trust's 13F filing for Q4 2019, filed 15 Jan 2020.